Colgate-Palmolive Has Strong Brand-Building And Analytics-Driven Marketing Strategy, Says Analyst
Colgate-Palmolive Has Strong Brand-Building And Analytics-Driven Marketing Strategy, Says Analyst
BofA Securities analyst Bryan Spillane reiterated a Buy rating on the shares of Colgate-Palmolive Company (NYSE:CL) and raised the price target from $90 to $100.
美銀證券分析師布萊恩·斯皮蘭重申了對高露潔棕欖公司（紐約證券交易所代碼：CL）股票的買入評級，並將目標股價從90美元上調至100美元。
CL opened the year with organic sales growth of +9.8% and high-quality EPS of $0.86 versus the analyst's estimate of $0.82.
CL在今年年初的有機銷售增長了9.8％，高質量的每股收益爲0.86美元，而分析師的估計爲0.82美元。
Pricing growth of +8.5% exceeded the analyst's forecast by +410 basis points, helping deliver 330 basis points of gross margin expansion that drove the +150 basis points beat vs the analyst's estimates.
+8.5％的定價增長比分析師的預測高出410個點子，幫助實現了330個點子的毛利率增長，推動了超過分析師預期的+150個點子。
Hyperinflation in Argentina, Africa, and the Mid-East was largely responsible for the upside as evidenced by the widest outperformance by segment in Latam and Africa/Eurasia.
阿根廷、非洲和中東的惡性通貨膨脹是上行的主要原因，拉美和非洲/歐亞大陸各細分市場的表現最爲明顯的跑贏大盤就證明了這一點。
Share gains in North America is a testament to Colgate's brand-building and analytics-driven marketing strategy.
北美的股價上漲證明了高露潔的品牌建設和以分析爲導向的營銷策略。
The analyst highlighted both EPS outperformance and meaningfully higher marketing spend, to which management attributed the favorable market share gains across markets, including the U.S.
該分析師強調了每股收益的跑贏大盤和明顯增加的營銷支出，管理層將包括美國在內的各市場的有利市場份額增長歸因於此。
For the second quarter, the analyst forecasts an organic growth of +5.8% Y/Y, noting easier North America comps and China improvement but less Latam pricing, with $0.85 of EPS.
該分析師預測第二季度有機增長同比增長5.8％，他指出，北美的業績較爲寬鬆，中國的情況有所改善，但拉美的定價有所降低，每股收益爲0.85美元。
For FY24, the analyst raised the organic sales growth estimate from +4.5% to +6.5%, mostly on higher pricing to offset incremental FX and keep EPS of $3.50 unchanged.
該分析師將24財年的有機銷售增長預期從+4.5％上調至+6.5％，這主要是由於提高定價以抵消外匯增量並保持每股收益3.50美元不變。
The increased price target implies a target P/E multiple of 26.5x to the analyst's FY25e EPS.
目標股價的提高意味着目標市盈倍數是分析師25財年每股收益的26.5倍。
It represents a 2.5x increase and a 30% premium to peers above the flat historical average, supported by favorable volume trends, pricing, and margin power as market share momentum continues to build.
隨着市場份額勢頭的持續增強，它增長了2.5倍，比同行高出30％的溢價，這得益於有利的交易量趨勢、定價和利潤能力。
Price Action: CL shares are trading lower by 0.87% at $90.22 at the last check Monday.
價格走勢：週一最後一次檢查時，CL股價下跌0.87％，至90.22美元。
Photo by thetaxhaven via Flickr
照片由 thetaxhaven 通過 Flickr 拍攝
譯文內容由第三人軟體翻譯。